Topics

Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Gaucher Disease, Date of authorisation: 18/02/2019, Status: Authorised

05:11 EDT 2 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Gaucher Disease, Date of authorisation: 18/02/2019, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Gaucher Disease, Date of authorisation: 18/02/2019, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Gaucher Disease, Date of authorisation: 18/02/2019, Status: Authorised"

Quick Search